Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Robert D. Okada"'
Publikováno v:
Echocardiography. 29:E39-E42
A 41-year-old woman with a history of neurocardiogenic syncope treated with beta-blockers was admitted with chest pain. Dobutamine echocardiogram images demonstrated decreased global LV systolic wall motion and thickening. Coronary angiograms were no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39230fb57c5d5a54c3a53f8a375eae37
https://doi.org/10.1111/j.1540-8175.2011.01538.x
https://doi.org/10.1111/j.1540-8175.2011.01538.x
Publikováno v:
Annals of Nuclear Medicine. 22:617-627
To compare the myocardial kinetics of three (99m)technetium-labeled monocationic tracers [methoxy-isobutylisonitrile (MIBI), tetrofosmin, and Q12] in a model of ischemia-reperfusion (IR) to determine their abilities to assess myocardial viability.Iso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49e549dd9053b0107e380b6746cbde0
https://doi.org/10.1007/s12149-008-0155-y
https://doi.org/10.1007/s12149-008-0155-y
Autor:
Gerald Johnson, David R. Okada, Sonia D. Hocherman, Delia Beju, Zhonglin Liu, Robert D. Okada
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 35:570-578
(99m)Tc-sestamibi has been proposed as a viability imaging agent. The purposes of this study were: (1) to determine the relationship between myocardial viability and (99m)Tc-sestamibi kinetics using perfused rat heart models across a full spectrum of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf49b9d38d36a34f91d14252fd34ad0
https://doi.org/10.1007/s00259-007-0549-4
https://doi.org/10.1007/s00259-007-0549-4
99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium
Autor:
Ban-An Khaw, Curtis Hart, Sonia D. Hocherman, Gerald Johnson, Robert D. Okada, Zhonglin Liu, Christine C. Okada
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 33:319-328
(99m)Tc-glucarate is an imaging agent developed for the detection of acutely infarcted myocardium. The purposes of the current study were to (1) determine whether (99m)Tc-glucarate can detect acute infarct in the setting of only partial minimal reper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67993387c5005574975c3ddfb7c694c5
https://doi.org/10.1007/s00259-005-1913-x
https://doi.org/10.1007/s00259-005-1913-x
Autor:
Ban-An Khaw, K. Y. Pak, Z. Liu, S. D. Hocherman, Gerald Johnson, Robert D. Okada, D. R. Okada
Publikováno v:
Journal of Nuclear Cardiology. 10:168-176
Technetium-99m glucarate is a myocardial infarct-avid imaging agent. Recent conflicting and inconclusive reports have suggested that the agent may be taken up by ischemic but viable myocardium. The purposes of this study were (1) to determine conclus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b423eaba547c1b27798c8ad7b25e35
https://doi.org/10.1067/mnc.2003.1
https://doi.org/10.1067/mnc.2003.1
Publikováno v:
EJNMMI Research
Background Recent technical developments using solid-state technology have enabled rapid image acquisition with single photon emission computed tomography (SPECT) and have led to a renewed interest in technetium-99m-teboroxime (Tc-99m-teboroxime) as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90eeb0514f78daec7d36fd3af32a680c
https://doi.org/10.1186/s13550-014-0042-6
https://doi.org/10.1186/s13550-014-0042-6
Publikováno v:
Journal of Nuclear Cardiology. 6:306-315
Technetium 99m-HL91 is a new hypoxia imaging agent that demonstrates increased uptake in ischemic, viable myocardium. This study was performed to determine whether HL91 is taken up by nonviable myocardium.Twenty-three Krebs-Henseleit buffer-perfused,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76423367f536005ad1ac24f2d0103b4
https://doi.org/10.1016/s1071-3581(99)90043-0
https://doi.org/10.1016/s1071-3581(99)90043-0
Publikováno v:
Journal of Nuclear Cardiology. 5:285-294
Objective . 99mTc-HL-91 (Prognox) is a potential new hypoxia-avid myocardial imaging agent. The purpose of this study was to determine whether this tracer would demonstrate increased activity in nonviable myocardium in vivo. Methods and Results . A 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd4f0f78da0c996cfbde08d7d9412972
https://doi.org/10.1016/s1071-3581(98)90130-1
https://doi.org/10.1016/s1071-3581(98)90130-1
Publikováno v:
Journal of Nuclear Cardiology. 4:217-225
(99m)Tc-labeled (bis(N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium(V)) ([99m]TcN-NOET) is a new lipophilic, neutral-charge cardiac perfusion imaging agent that demonstrates apparent redistribution in animal models and humans. The purpose of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6593415aa29e4dd187cd2f6ada07f5ce
https://doi.org/10.1016/s1071-3581(97)90082-9
https://doi.org/10.1016/s1071-3581(97)90082-9
Autor:
Robert D. Okada, Barbara Edwards, James D. Kelly, Gerald Johnson, Colin M. Archer, Kiem N. Nguyen
Publikováno v:
Circulation. 95:1892-1899
Background 99m Tc-HL91 is a potential imaging agent that has demonstrated increased uptake in hypoxic tumor cells. The purpose of this study was to determine if 99m Tc-HL91 demonstrates increased uptake and retention in ischemic and hypoxic myocardiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb50fcf30fc94d3586484a1684bae48e
https://doi.org/10.1161/01.cir.95.7.1892
https://doi.org/10.1161/01.cir.95.7.1892